SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,895.74 315.20
( 0.43%)

Global Indices

Nasdaq

51,839.66 468.68
(0.91%)

Dow Jones

7,763.25 38.12
(0.49%)

Hang Seng

66,308.10 794.11
(1.21%)

Nikkei 225

10,694.57 14.58
(0.14%)

Forex

USD-INR

95.89 0.16
(0.16%)

EUR-INR

109.08 -0.12
(-0.11%)

GBP-INR

126.82 -0.30
(-0.24%)

JPY-INR

0.60 0.00
(-0.20%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Glaxosmithkline Pharmaceuticals Ltd

Industry : Pharmaceuticals - Multinational

BSE Code

ISIN Demat

Book Value()

500660

INE159A01016

132.2958859

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GLAXO

45.08

47719.14

EPS(TTM)

Face Value()

Div & Yield %

62.48

2.02

Back

Jay Shree Tea & Industries reports consolidated net loss of Rs 5.94 crore in the June 2026 quarter

Aug 13,2026

Net Loss of Jay Shree Tea & Industries reported to Rs 5.94 crore in the quarter ended June 2026 as against net loss of Rs 8.98 crore during the previous quarter ended June 2025. Sales rose 8.61% to Rs 206.17 crore in the quarter ended June 2026 as against Rs 189.82 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	206.17	189.82	9
OPM %	2.68	-0.23	-
PBDT	-0.26	-3.37	92
PBT	-5.94	-8.98	34
NP	-5.94	-8.98	34

73,895.74 315.20 ( 0.43%)

51,839.66 468.68 (0.91%)

7,763.25 38.12 (0.49%)

66,308.10 794.11 (1.21%)

10,694.57 14.58 (0.14%)

95.89 0.16 (0.16%)

109.08 -0.12 (-0.11%)

126.82 -0.30 (-0.24%)

0.60 0.00 (-0.20%)